Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines
Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines ...
Read MoreSelect Page
Posted by Bladder Cancer Journal | May 2018
Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines ...
Read MorePosted by Bladder Cancer Journal | May 2018
Thromboembolism in Patients with Bladder Cancer: Incidence, Risk Factors and Prevention ...
Read MorePosted by Bladder Cancer Journal | May 2018
Transversus Abdominis Plane Blockade as Part of a Multimodal Postoperative Analgesia Plan in...
Read MorePosted by Bladder Cancer Journal | May 2018
Naturally-Occurring Canine Invasive Urothelial Carcinoma: A Model for Emerging Therapies ...
Read MorePosted by Sam S. Chang, MD, MBA | Feb 2018
Sam Chang, MD, MBA, who has served as chair of the American Urological Association (AUA) guidelines panel for non-muscle invasive bladder cancer (NMIBC) and muscle invasive bladder cancer (MIBC), provides an overview of updated non-metastatic MIBC treatment guidelines, including a comprehensive treatment algorithm. He also discusses directions of future research for the disease.
Read More